Diet Drug Report -- News about prescription and over-the-counter diet drugs

DietDrugReport

Free Email

News Alerts!

Your INDEPENDENT source of news about prescription and over-the-counter diet drugs

Latest News and Reviews of Weight-Loss Drugs and Diet Supplements

Prescription Drugs

Non-Prescription Drugs

Drugs Under Development

Weight-Loss Drug Studies

What Doctors Say

Diet Supplements

Buying Weight-Loss Products

	Diet Drug News -- 2006 News Archive
	Diet Drug News for December 2006 -- News About Weight-Loss Medications
	Merck Diet Drug Like Rimonabant on Track for FDA Consideration in 2008 FDA Puts Diet Pill Rimonabant (Acomplia / Zimulti) on Slow Track for Review Merck Diet Pill Like Rimonabant -- But at Far Lower Dose -- in Phase III Trial Diet Pill Acomplia Significant Help in Type 2 Diabetes Treatment Trial Data to Show Diet Pill Rimonabant Can Help Control Type 2 Diabetes
	Diet Drug News for November 2006 -- News About Weight-Loss Medications
	Pfizer Says Diet Drug Acomplia (Rimonabant) May Soon Have Competitors Psychiatric Disorders Reported in European Rimonabant Patients Diet Pill Rimonabant Seen on Slow FDA Track for U.S. Approval Decision Diet Pill Acomplia Gets First North American Approval in Mexico
	Diet Drug News for October 2006 -- News About Weight-Loss Medications
	Diet Pill Rimonabant Seen Needing More Testing as Diabetes Treatment Diabetes Drug Company Pressing on With Trials of Pramlintide as Diet Drug More Details Reported on Promising Trial for Experimental Diet Drug Qnexa Diabetes Drug Liraglutide to Be Tested in Separate Trial as Diet Drug Sanofi: FDA Not Seeking More European Safety Data for Diet Pill Acomplia Experimental Diet Drug Contrave Produces Promising Results in Small Trial Merck Abandons A Diet Pill, But Trials of Drug Similar to Acomplia Continue Discussion Forum for Diet Pill Acomplia Users Launched by Acomplia Report
	Diet Drug News for September 2006 -- News About Weight-Loss Medications
	Study: O-T-C Strength Xenical Produces Weight Loss, Other Benefits Study: Diet Pill Xenical (Orlistat) Aids Glucose Control in Diabetics Study: Diet Drug Xenical (Orlistat) Helps Obese Teens Lose Weight
	Diet Drug News for August 2006 -- News About Weight-Loss Medications
	FDA Ban on Diet Pills Containing Ephedra Reinstated by Appeals Court Nastech in New Bid to Find Optimal Nasal Spray Dose for Diet Drug PYY3-36 Rimonabant Safety for Obese Individuals With Mild Depression Questioned Sanofi 'Hopeful,' But U.S. Outlook for Diet Drug Acomplia Remains Cloudy Operators of Internet Pharmacy That Sold Diet Pills Indicted by Grand Jury Alizyme in Agreement With FDA on Phase III Trial for Diet Pill Cetilistat
	Diet Drug News for July 2006 -- News About Weight-Loss Medications
	Diet Pill Meridia Helps Very Obese Young Teens Lose Weight in Trial Mildly Encouraging Results Reported From Unusual Japanese Diet Pill Trial How Much Room Does Price of Acomplia Leave for Alli (Low-Dose Xenical)? Acomplia Draws 'Wonder Drug' Headlines, But Do These Help Sanofi
	Diet Drug News for June 2006 -- News About Weight-Loss Medications
	Price of Diet Pill Acomplia (Rimonabant) in Britain Less Than Expected Diet Pill Acomplia (Rimonabant) on Sale for About $100 per Month in Britain Sanofi Diet Pill Acomplia (Rimonabant) to Go on Sale in Britain in July Pfizer Licenses Promising Diet Drug in Early Trials From Bayer Diet Drug Lorcaserin (Formerly ADP356) Seen Promising in Phase 2b Trial Diet Drug Xenical Under Renewed Attack by Consumer Advocates Can Americans Get Diet Pill Acomplia From Europe This Summer?
	Diet Drug News for May 2006 -- News About Weight-Loss Medications
	Sanofi Hopes to Answer All FDA Questions on Rimonabant 'by Summertime' No Early FDA Action on Diet Pill Acomplia (Rimonabant) Now Seems Likely Wyeth Moves Another Step Closer to Final Resolution of "Fen-phen" Claims Concerns Over Safety of Diet Drug Acomplia Reported Likely to Linger Promising Early Results Reported for Experimental Diet Drug Qnexa FDA Asks Appellate Court to Restore Ban on Weight-Loss Aid Ephedra Diet Pill to Be Sold as Acomplia in Europe, But Zimulti Looks Likely in U.S. Sanofi: Diet Pill Acomplia May Make Debut in Britain or Germany in July Acomplia Draws Fresh Burst of Optimism From European-Based Analyst
	Diet Drug News for April 2006 -- News About Weight-Loss Medications
	Sanofi Appears to Plan Different Names for Acomplia in Europe and U.S. Meridia Tied to Abnormal Heart Rhythms for Some With Heart Condition European Union Panel Backs Approval of Diet Pill Acomplia (Rimonabant) Glaxo Launches Weight-Loss Website Prior to FDA Action on Alli (Xenical) One Dead, Five Hospitalized After Taking Diet Pills in France Stock Guru Offers Gloomier View on FDA Timeline for Action on Acomplia Consumer Advocates Urge FDA to Pull Xenical (Orlistat) From the Market Sanofi's Acomplia May Face Early Competition from Similar Merck Drug FDA Finds Low-Dose Xenical 'Approvable' for Over-the-Counter Sale as Alli Sanofi's Acomplia May Reduce Bariatric Surgery for Morbid Obesity Sanofi Hints Acomplia Approval Also Sought for 'Metabolic Disorders'
	Diet Drug News for March 2006 -- News About Weight-Loss Medications
	Arena Reports Progress on APD356; Phase III Trials to Start Later This Year Harvard Researchers Say FDA Approval of Alli (O-T-C Orlistat) Is Uncertain European Commission Warns Fake Acomplia Is Being Sold on Internet Sanofi Provides No Information on Its FDA Meeting on Acomplia Will Nomination of FDA Chief Speed or Slow Action on Acomplia? Hopes for Early Action on Acomplia Dim as Advisory Panel Scrubs Meeting When Will Sanofi Come Clean on Acomplia and the FDA? Merck Gives Up on Diet Drug PYY3-36, Cites Disappointing Study Diabetes Drug Byetta Gaining Attention as Weight-Loss Aid Acomplia's Rejection as a Smoking-Cessation Aid: What's the Real Story? Report: Sanofi Selectively Disclosed Acomplia News to Favored Analysts
	Diet Drug News for February 2006 -- News About Weight-Loss Medications
	Acomplia May Be Available in Europe or Mexico Before United States Is There Any Factual Basis to Sanofi's New Forecast on Acomplia Approval Sanofi Says No New Weight-Loss Trial Needed for Acomplia Approval News About Future of Acomplia Seen Likely on Friday, Feb. 24th Analyst Speculation on Acomplia Approval Seen Shifting Toward 2007 FDA Had Bad News on Acomplia for Sanofi, But How Bad? FDA: Acomplia Rejected As Aid to Smoking Cessation FDA: Acomplia May Be 'Approvable' for Weight Loss, But Not Ready Yet Why Did So Many Getting Acomplia in Trial Quit Taking It Along the Way? NIH Researcher Urges Longer Look at Acomplia Safety Before Approval Concern Over Acomplia Side Effects Seen Likely to Delay FDA Approval Old Acomplia Trial Results Create New Excitement When Reported in JAMA Indian Pharma Reports Early Progress on Drug That Works Like Acomplia Wyeth Hoping to Settle Remaining "Fen-phen" Lawsuits Within Two Years Sanofi: Acomplia Could Be on Market by June 30 With Feb. OK from FDA Study Downplays Link Between Cortisol and Obesity New Acomplia Trial Announced, But Enrollment Said Amost Completed
	Diet Drug News for January 2006 -- News About Weight-Loss Medications
	Sanofi Expresses Confidence Acomplia Will Be on Market in U.S. Soon FDA Advisory Panels Back Over-the-Counter Sale of Low-Dose Xenical FDA Raises Warning Flags on Over-the-Counter Sale of Low-Dose Xenical FDA Warns Consumers Not to Take Two Brazilian Weight Loss Supplements Article Calls on FDA to Limit Acomplia to Those "Who Need It to Survive" Report: Acomplia Could Be Approved by FDA 'As Early as Next Month' Report: Acomplia Still Must Overcome "Skepticism About Its Side Effects"
	Diet Drug Report -- 2006 News Archive
	Diet Drug Report -- 2005 News Archive

Other Diet Resources

Privacy Policy | Terms and Disclaimers | About the Diet Drug Report

Contact Us

We subscribe to the HONcode principles of the HON Foundation.

This is an independent news site reporting on prescription and over-the-counter diet drugs and on the more than 200 additional diet drugs currently in various stages of development. . Nothing on this site is intended to infringe on any trademarks. Nothing on this site is intended as medical advice. The information provided is for informational purposes only. Always consult a doctor or medical professional with questions regarding a medical condition.